What question did this study set out to answer?

To assess the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative placement of a levonorgestrel-releasing intrauterine system for symptomatic adenomyosis.

November 10, 2020Journal of obstetrics and gynaecology research

Laparoscopic adenomyomectomy combined with levonorgestrel‐releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness

View Full Paper

Ask AI

Bookmark

Authors

FSFeng SunMicrosoft (United States)YZYe ZhangZhejiang Chinese Medical University MYMin YouQingdao University

Discussion

Member takes

Implication

Case series shows laparoscopic adenomyomectomy with an intrauterine device significantly reduces pain and bleeding in adenomyosis, indicating a viable uterus-sparing approach.

Key Points

To assess the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative placement of a levonorgestrel-releasing intrauterine system for symptomatic adenomyosis.
Conducted a university medical center case-series study of 52 patients with symptomatic adenomyosis treated between January 2015 and July 2018.
Evaluated changes in visual analog scale scores, menstrual flow, uterine volume, and adverse events preoperatively and at 3, 12, and 24 months postoperatively.
Mean visual analog scale scores, menstrual flow scores, and uterine volume decreased significantly at 3, 12, and 24 months post-surgery compared with preoperative baselines (all P < 0.001).
Clinical effectiveness rates were 98% at 3 months and 96% at 12 and 24 months for dysmenorrhea, and 97.6% at 3 months and 95.2% at 12 and 24 months for menorrhagia.
Reported adverse events included amenorrhea in 23.1% (n = 12), device expulsion in 3.8% (n = 2), and uterine perforation in 1.9% (n = 1), with no surgical conversions to laparotomy.

Cite This Study

Sun et al. (2020) studied this question.

synapsesocial.com/papers/6a71557c8031ec7bb1dce6fb https://doi.org/10.1111/jog.14571

View Full Paper

Ask AI

Bookmark

November 10, 2020Journal of obstetrics and gynaecology research

Laparoscopic adenomyomectomy combined with levonorgestrel‐releasing intrauterine system in the treatment of adenomyosis: Feasibility and effectiveness

View Full Paper

Ask AI

Bookmark

Authors

FSFeng SunMicrosoft (United States)YZYe ZhangZhejiang Chinese Medical University MYMin YouQingdao University

Discussion

Member takes

Implication

Case series shows laparoscopic adenomyomectomy with an intrauterine device significantly reduces pain and bleeding in adenomyosis, indicating a viable uterus-sparing approach.

Key Points

To assess the clinical efficacy and safety of laparoscopic adenomyomectomy combined with intraoperative placement of a levonorgestrel-releasing intrauterine system for symptomatic adenomyosis.
Conducted a university medical center case-series study of 52 patients with symptomatic adenomyosis treated between January 2015 and July 2018.
Evaluated changes in visual analog scale scores, menstrual flow, uterine volume, and adverse events preoperatively and at 3, 12, and 24 months postoperatively.
Mean visual analog scale scores, menstrual flow scores, and uterine volume decreased significantly at 3, 12, and 24 months post-surgery compared with preoperative baselines (all P < 0.001).
Clinical effectiveness rates were 98% at 3 months and 96% at 12 and 24 months for dysmenorrhea, and 97.6% at 3 months and 95.2% at 12 and 24 months for menorrhagia.
Reported adverse events included amenorrhea in 23.1% (n = 12), device expulsion in 3.8% (n = 2), and uterine perforation in 1.9% (n = 1), with no surgical conversions to laparotomy.

Cite This Study

Sun et al. (2020) studied this question.

synapsesocial.com/papers/6a71557c8031ec7bb1dce6fb https://doi.org/10.1111/jog.14571

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark